Beyond Air (XAIR) Competitors

IceCure Medical (NASDAQ:ICCM) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, community ranking, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

Does the MarketBeat Community favor ICCM or XAIR?

Beyond Air received 22 more outperform votes than IceCure Medical when rated by MarketBeat users. However, 96.30% of users gave IceCure Medical an outperform vote while only 69.57% of users gave Beyond Air an outperform vote.

Company	Underperform	Outperform
IceCure Medical	Outperform Votes 26 96.30%	Underperform Votes 1 3.70%
Beyond Air	Outperform Votes 48 69.57%	Underperform Votes 21 30.43%

Do insiders and institutionals hold more shares of ICCM or XAIR?

0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 31.5% of Beyond Air shares are held by institutional investors. 2.4% of IceCure Medical shares are held by insiders. Comparatively, 20.1% of Beyond Air shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Do analysts recommend ICCM or XAIR?

IceCure Medical presently has a consensus price target of $2.50, suggesting a potential upside of 98.41%. Beyond Air has a consensus price target of $1.50, suggesting a potential upside of 669.63%. Given Beyond Air's higher possible upside, analysts clearly believe Beyond Air is more favorable than IceCure Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.50
Beyond Air	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.00

Is ICCM or XAIR more profitable?

IceCure Medical has a net margin of -376.85% compared to Beyond Air's net margin of -1,730.00%. IceCure Medical's return on equity of -124.44% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-376.85%	-124.44%	-87.70%
Beyond Air	-1,730.00%	-226.01%	-109.75%

Does the media prefer ICCM or XAIR?

In the previous week, Beyond Air had 2 more articles in the media than IceCure Medical. MarketBeat recorded 6 mentions for Beyond Air and 4 mentions for IceCure Medical. Beyond Air's average media sentiment score of 0.84 beat IceCure Medical's score of 0.58 indicating that Beyond Air is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IceCure Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Beyond Air	0 Very Positive mention(s)	4 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility & risk, ICCM or XAIR?

IceCure Medical has a beta of 0.43, meaning that its share price is 57% less volatile than the S&P 500. Comparatively, Beyond Air has a beta of 0.15, meaning that its share price is 85% less volatile than the S&P 500.

Which has higher valuation and earnings, ICCM or XAIR?

IceCure Medical has higher revenue and earnings than Beyond Air. IceCure Medical is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.29M	21.25	-$14.65M	-$0.30	-4.20
Beyond Air	$3.02M	4.44	-$60.24M	-$1.06	-0.18

Summary

IceCure Medical beats Beyond Air on 10 of the 18 factors compared between the two stocks.